![Antony D. Buss](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Antony D. Buss
Keine laufenden Positionen mehr
Profil
Antony D.
Buss served as President & Chief Executive Officer at MerLion Pharmaceuticals Pte Ltd.
from 2002 to 2011.
Prior to that, he held Principal positions at Bayer Schering Pharma AG, GSK Plc, and Pfizer SACI.
Buss earned a doctorate degree from the University of Cambridge in 1981 and a graduate degree from the University of East Anglia in 1978.
Ehemalige bekannte Positionen von Antony D. Buss
Unternehmen | Position | Ende |
---|---|---|
GSK PLC | Corporate Officer/Principal | - |
Pfizer SACI
![]() Pfizer SACI Medical/Nursing ServicesHealth Services Part of Pfizer Inc., Pfizer SACI is a company based in Buenos Aires, Argentina. | Corporate Officer/Principal | - |
Bayer Schering Pharma AG | Corporate Officer/Principal | - |
MerLion Pharmaceuticals Pte Ltd.
![]() MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Vorstandsvorsitzender | - |
Ausbildung von Antony D. Buss
University of Cambridge | Doctorate Degree |
University of East Anglia | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GSK PLC | Health Technology |
Private Unternehmen | 3 |
---|---|
Bayer Schering Pharma AG | Health Technology |
MerLion Pharmaceuticals Pte Ltd.
![]() MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Commercial Services |
Pfizer SACI
![]() Pfizer SACI Medical/Nursing ServicesHealth Services Part of Pfizer Inc., Pfizer SACI is a company based in Buenos Aires, Argentina. | Health Services |